DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Kwo P, Gitlin N, Nahass R. et al.
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.

Hepatology 2016;
64: 370-380

Download Bibliographical Data

Access:
Access: